JRCT ID: jRCT2080222231
Registered date:24/09/2013
A phase I study of oral BGJ398 in Asian patients
Basic Information
| Recruitment status | completed |
|---|---|
| Health condition(s) or Problem(s) studied | |
| Date of first enrollment | 31/01/2013 |
| Target sample size | 32 |
| Countries of recruitment | Japan,Asia except Japan |
| Study type | Interventional |
| Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : - Therapeutic category code : 429 Other antitumor agents Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : |
Outcome(s)
| Primary Outcome | safety |
|---|---|
| Secondary Outcome | efficacy pharmacokinetics |
Key inclusion & exclusion criteria
| Age minimum | >= 18age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | |
| Exclude criteria |
Related Information
| Primary Sponsor | |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | |
| Secondary ID(s) | NCT01697605,JapicCTI-132280 |